Penthrox receives regulatory approval in the UAE
9 September 2016
ASX ANNOUNCEMENT
Penthrox receives regulatory approval in the UAE
Medical Developments International Limited (ASX: MVP) is delighted to announce that it has received regulatory approval and the Marketing Authorisation (MA) for the sale of Penthrox in the United Arab Emirates (UAE).
The CEO of MVP, Mr. Sharman said: “Penthrox has been supplied for a number of years into the UAE on a “Named Patient Basis” and is used in many of the major private and public hospitals as well as the major Ambulance services.
For details relating to the full ASX release, please click on the following link: Penthrox receives regulatory approval in the UAE